ISSN 2149-2263 | E-ISSN 2149-2271
The Anatolian Journal of Cardiology
Reply to Letter to the Editor: “Can ARNI Prevent Doxorubicin-Induced Cardiotoxicity?” [Anatol J Cardiol]
Anatol J Cardiol. 2022; 26(4): 344-344 | DOI: 10.5152/AnatolJCardiol.2021.1371

Reply to Letter to the Editor: “Can ARNI Prevent Doxorubicin-Induced Cardiotoxicity?”

Ferhat Dindaş1, Hüseyin Güngör2, Mehmet Ekici3, Pınar Akokay4, Füsun Erhan5, Mustafa Doğduş1, Mehmet Birhan Yılmaz6
1Department of Cardiology, Faculty of Medicine, Uşak Training and Research Hospital, Uşak, Turkey
2Department of Pharmacology, Faculty of Veterinary, Cumhuriyet University, Sivas, Turkey
3Department of Physiology, Faculty of Veterinary, Cumhuriyet University, Sivas, Turkey
4Department of Histology, İzmir Kavram Vocational School, İzmir, Turkey
5Department of Histology, Faculty of Veterinary, Cumhuriyet University, Sivas, Turkey
6Department of Cardiology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey


Ferhat Dindaş, Hüseyin Güngör, Mehmet Ekici, Pınar Akokay, Füsun Erhan, Mustafa Doğduş, Mehmet Birhan Yılmaz. Reply to Letter to the Editor: “Can ARNI Prevent Doxorubicin-Induced Cardiotoxicity?”. Anatol J Cardiol. 2022; 26(4): 344-344

Corresponding Author: Ferhat Dindaş, Türkiye
Manuscript Language: English


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 The Anatolian Journal of Cardiology



Kare Publishing is a subsidiary of Kare Media.